Funded Tech Companies
Regentis Biomaterials
Wondering who provided funding to Regentis Biomaterials? Haisco Pharmaceutical Group, SCP Partners and Medica Venture Partners joined the equity holders in this innovative medical devices company.
Company Overview
Company Name
Regentis Biomaterials
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
12 Ha'ilan St. Northern Industrial Zone P.O.Box 260
Or-Akiva, 3060000
Israel
Or-Akiva, 3060000
Israel
Phone
Website
Email Address
Company Background Information
Overview
Regentis Biomaterials is a medical material development company that is focused on commercializing its patent-applied Gelrin Platform Technology for bone, spine and cartilage repair.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/11/2016
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alastair Clemow
Chief Scientific Officer
Dror Seliktar
General Manager
Livnat Ben-Zur
VP - R & D
Roni Wechsler
VP - Regulatory Affairs
Brooke Mastrorio
Company Investors
- Haisco Pharmaceutical Group
- SCP Partners
- Medica Venture Partners
- Generali Financial Holdings
- Technion Research & Development Foundation
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs